Literature DB >> 10805362

Association of lower genital tract inflammation with objective evidence of endometritis.

J F Peipert1, R B Ness, D E Soper, D Bass.   

Abstract

The purpose of this report is to evaluate the association between lower genital tract inflammation and objectively diagnosed endometritis. We analyzed the first 157 patients enrolled in the PEACH study, a multicenter randomized clinical trial designed to compare the effectiveness of outpatient and inpatient therapy for PID. Women less than 38 years of age, who presented with a history of pelvic discomfort for 30 days or less and who were found to have pelvic organ tenderness (uterine or adnexal tenderness) on bimanual examination, were initially invited to participate. After recruitment of the first 58 patients (group 1) we added the presence of leukorrhea, mucopurulent cervicitis, or untreated positive test for N. gonorrhoeae or C. trachomatis to the inclusion criteria (group 2, N = 99). We compared rates of endometritis in the two groups and calculated the sensitivity, specificity, and predicted values of the presence of white blood cells in the vaginal wet preparation. The rate of upper genital tract infection in group 1 was 46.5% (27/58) compared to 49.5% (49/99) in group 2. Microbiologic evidence of either N. gonorrhoeae or C. trachomatis increased from 22.4% in group 1 to 38.3% in group 2. The presence of vaginal white blood cells or mucopus has a high sensitivity (88.9%), but a low specificity (19.4%) for the diagnosis of upper genital-tract infection. Assessment of the lower genital tract for evidence of infection or inflammation is a valuable component of the diagnostic evaluation of pelvic inflammatory disease. The presence of either mucopus or vaginal white blood cells is a highly sensitive test for endometritis in patients with pelvic pain and tenderness.

Entities:  

Mesh:

Year:  2000        PMID: 10805362      PMCID: PMC1784668          DOI: 10.1002/(SICI)1098-0997(2000)8:2<83::AID-IDOG4>3.0.CO;2-4

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

1.  Self-reported pelvic inflammatory disease in the United States, 1988.

Authors:  S O Aral; W D Mosher; W Cates
Journal:  JAMA       Date:  1991-11-13       Impact factor: 56.272

Review 2.  Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy.

Authors:  T G Burnakis; N B Hildebrandt
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

3.  Laboratory evaluation of acute upper genital tract infection.

Authors:  J F Peipert; L Boardman; J W Hogan; J Sung; K H Mayer
Journal:  Obstet Gynecol       Date:  1996-05       Impact factor: 7.661

4.  Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis.

Authors:  N B Kiviat; P Wølner-Hanssen; D A Eschenbach; J N Wasserheit; J A Paavonen; T A Bell; C W Critchlow; W E Stamm; D E Moore; K K Holmes
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

5.  Bacterial vaginosis as a risk factor for upper genital tract infection.

Authors:  J F Peipert; A B Montagno; A S Cooper; C J Sung
Journal:  Am J Obstet Gynecol       Date:  1997-11       Impact factor: 8.661

6.  Oral contraception and the recognition of endometritis.

Authors:  R B Ness; L M Keder; D E Soper; A J Amortegui; J Gluck; H Wiesenfeld; R L Sweet; P A Rice; J F Peipert; S P Donegan; A Kanbour-Shakir
Journal:  Am J Obstet Gynecol       Date:  1997-03       Impact factor: 8.661

7.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

8.  Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis.

Authors:  A P Korn; N Hessol; N Padian; G Bolan; D Muzsnai; E Donegan; J Jonte; J Schachter; D V Landers
Journal:  Sex Transm Dis       Date:  1995 Nov-Dec       Impact factor: 2.830

Review 9.  Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

10.  Design of the PID Evaluation and Clinical Health (PEACH) Study.

Authors:  R B Ness; D E Soper; J Peipert; S J Sondheimer; R L Holley; R L Sweet; D L Hemsell; H Randall; S L Hendrix; D C Bass; S F Kelsey; T J Songer; J R Lave
Journal:  Control Clin Trials       Date:  1998-10
View more
  6 in total

1.  Nongonococcal and Nonchlamydial Cervicitis.

Authors:  Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections.

Authors:  W M Geisler; S Yu; M Venglarik; J R Schwebke
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

3.  Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis.

Authors:  Linda M Gorgos; Laura K Sycuro; Sujatha Srinivasan; Tina L Fiedler; Martin T Morgan; Jennifer E Balkus; R Scott McClelland; David N Fredricks; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2015-09       Impact factor: 2.830

4.  Colonization of second-trimester placenta parenchyma.

Authors:  Andrew B Onderdonk; Jonathan L Hecht; Thomas F McElrath; Mary L Delaney; Elizabeth N Allred; Alan Leviton
Journal:  Am J Obstet Gynecol       Date:  2008-03-07       Impact factor: 8.661

5.  Characterization of allergic inflammation in chronic uterine cervicitis.

Authors:  Fei Ma; Jun Liu; Xiaodan Lv; Hua-Zhen Liu; Ping-Chang Yang; Yan Ning
Journal:  Clin Exp Immunol       Date:  2022-01-28       Impact factor: 4.330

6.  The Role of Polymorphonuclear Leukocyte Counts from Urethra, Cervix, and Vaginal Wet Mount in Diagnosis of Nongonococcal Lower Genital Tract Infection.

Authors:  Ivana Randjelovic; Amir Moghaddam; Birgitte Freiesleben de Blasio; Harald Moi
Journal:  Infect Dis Obstet Gynecol       Date:  2018-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.